Dassault Systèmes remains a hold as Q2 2026 showed Industrial Innovation growth and margin improvement, but Life Sciences revenue continues to decline. DASTY's acquisition of ArisGlobal introduces execution risk at a steep >10x sales multiple, requiring strong integration and cross-selling to justify the price. Industrial Innovation's 5% growth and customer wins suggest a return to healthy demand, but Life Sciences recovery is not yet convincing.
Dassault Systèmes SE (DASTY) Q2 2026 Earnings Call Transcript
The French company agreed to buy the U.S. supplier of software to the life-sciences industry, seeking to bolster its artificial-intelligence offering.
| Software Industry | Information Technology Sector | Pascal Daloz CEO | XMUN Exchange | US2375451083 ISIN |
| FR Country | 24,997 Employees | 26 May 2026 Last Dividend | 23 Jul 2014 Last Split | 28 Jun 1996 IPO Date |
Dassault Systèmes SE is a global leader in providing software solutions and services. Established in 1981 and headquartered in Vélizy-Villacoublay, France, the company operates worldwide, serving a diverse range of industries including transportation and mobility, industrial equipment, aerospace and defense, high-tech, life sciences and healthcare, and more. Its offerings are designed to support the entire lifecycle of products from concept through design, production, and management, enabling businesses to innovate more efficiently and effectively. With a comprehensive product portfolio that caters to various aspects of product development, Dassault Systèmes SE leverages its expertise to enhance the operations of companies across multiple sectors.